4p9l - Revision history

OCA at 00:41, 28 December 2023

OCA — Thu, 28 Dec 2023 00:41:43 GMT

←Older revision		Revision as of 00:41, 28 December 2023
Line 4:		Line 4:
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[4p9l]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4P9L OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4P9L FirstGlance]. <br>		<table><tr><td colspan='2'>[[4p9l]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4P9L OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4P9L FirstGlance]. <br>
-	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4p9l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4p9l OCA], [https://pdbe.org/4p9l PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4p9l RCSB], [https://www.ebi.ac.uk/pdbsum/4p9l PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4p9l ProSAT]</span></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.4361Å</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4p9l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4p9l OCA], [https://pdbe.org/4p9l PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4p9l RCSB], [https://www.ebi.ac.uk/pdbsum/4p9l PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4p9l ProSAT]</span></td></tr>
	</table>		</table>
	== Function ==		== Function ==

OCA at 12:48, 1 February 2023

OCA — Wed, 01 Feb 2023 12:48:31 GMT

←Older revision		Revision as of 12:48, 1 February 2023
Line 3:		Line 3:
	<StructureSection load='4p9l' size='340' side='right'caption='[[4p9l]], [[Resolution\|resolution]] 1.44Å' scene=''>		<StructureSection load='4p9l' size='340' side='right'caption='[[4p9l]], [[Resolution\|resolution]] 1.44Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4p9l]] is a 1 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Lk3_transgenic_mice Lk3 transgenic mice~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4P9L OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4P9L FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4p9l]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4P9L OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4P9L FirstGlance]. <br>
-	</td></tr>~~<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4pni\|4pni]]</td></tr>~~	+	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4p9l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4p9l OCA], [https://pdbe.org/4p9l PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4p9l RCSB], [https://www.ebi.ac.uk/pdbsum/4p9l PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4p9l ProSAT]</span></td></tr>
-	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">Ryr2 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=10090 LK3 transgenic mice])</td></tr>	+
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4p9l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4p9l OCA], [~~http~~://pdbe.org/4p9l PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=4p9l RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/4p9l PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=4p9l ProSAT]</span></td></tr>	+
	</table>		</table>
	== Function ==		== Function ==
-	[~~[http~~://www.uniprot.org/uniprot/RYR2_MOUSE RYR2_MOUSE]] Calcium channel that mediates the release of Ca(2+) from the sarcoplasmic reticulum into the cytoplasm and thereby plays a key role in triggering cardiac muscle contraction. Aberrant channel activation can lead to cardiac arrhythmia. In cardiac myocytes, calcium release is triggered by increased Ca(2+) levels due to activation of the L-type calcium channel CACNA1C. The calcium channel activity is modulated by formation of heterotetramers with RYR3. Required for cellular calcium ion homeostasis. Required for embryonic heart development.<ref>PMID:10473538</ref> <ref>PMID:9628868</ref> <ref>PMID:21098440</ref> <ref>PMID:20431056</ref>	+	[https://www.uniprot.org/uniprot/RYR2_MOUSE RYR2_MOUSE] Calcium channel that mediates the release of Ca(2+) from the sarcoplasmic reticulum into the cytoplasm and thereby plays a key role in triggering cardiac muscle contraction. Aberrant channel activation can lead to cardiac arrhythmia. In cardiac myocytes, calcium release is triggered by increased Ca(2+) levels due to activation of the L-type calcium channel CACNA1C. The calcium channel activity is modulated by formation of heterotetramers with RYR3. Required for cellular calcium ion homeostasis. Required for embryonic heart development.<ref>PMID:10473538</ref> <ref>PMID:9628868</ref> <ref>PMID:21098440</ref> <ref>PMID:20431056</ref>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 27:		Line 25:
	</StructureSection>		</StructureSection>
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: ~~Lk3 transgenic mice~~]]	+	[[Category: Mus musculus]]
-	[[Category: Lau, K]]	+	[[Category: Lau K]]
-	[[Category: Petegem, F ~~Van]]~~	+	[[Category: Van Petegem F]]
-	~~[[Category: Calcium]]~~	+
-	~~[[Category: Ion channel]]~~	+
-	~~[[Category: Metal transport]]~~	+
-	~~[[Category: Signalling]]~~	+
-	~~[[Category: Transport protein~~]]	+

OCA at 07:45, 8 January 2020

OCA — Wed, 08 Jan 2020 07:45:43 GMT

←Older revision		Revision as of 07:45, 8 January 2020
Line 1:		Line 1:

	==Crystal Structure of mouse Ryanodine Receptor 2 SPRY2 Domain (1080-1253) disease mutant A1107M==		==Crystal Structure of mouse Ryanodine Receptor 2 SPRY2 Domain (1080-1253) disease mutant A1107M==
-	<StructureSection load='4p9l' size='340' side='right' caption='[[4p9l]], [[Resolution\|resolution]] 1.44Å' scene=''>	+	<StructureSection load='4p9l' size='340' side='right'caption='[[4p9l]], [[Resolution\|resolution]] 1.44Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[4p9l]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Lk3_transgenic_mice Lk3 transgenic mice]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4P9L OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4P9L FirstGlance]. <br>		<table><tr><td colspan='2'>[[4p9l]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Lk3_transgenic_mice Lk3 transgenic mice]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4P9L OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4P9L FirstGlance]. <br>
Line 21:		Line 21:

	==See Also==		==See Also==
-	*[[Ryanodine receptor\|Ryanodine receptor]]	+	*[[Ryanodine receptor 3D structures\|Ryanodine receptor 3D structures]]
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Large Structures]]
	[[Category: Lk3 transgenic mice]]		[[Category: Lk3 transgenic mice]]
	[[Category: Lau, K]]		[[Category: Lau, K]]

OCA at 06:09, 18 April 2018

OCA — Wed, 18 Apr 2018 06:09:21 GMT

←Older revision		Revision as of 06:09, 18 April 2018
Line 3:		Line 3:
	<StructureSection load='4p9l' size='340' side='right' caption='[[4p9l]], [[Resolution\|resolution]] 1.44Å' scene=''>		<StructureSection load='4p9l' size='340' side='right' caption='[[4p9l]], [[Resolution\|resolution]] 1.44Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4p9l]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4P9L OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4P9L FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4p9l]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Lk3_transgenic_mice Lk3 transgenic mice]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4P9L OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4P9L FirstGlance]. <br>
	</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4pni\|4pni]]</td></tr>		</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4pni\|4pni]]</td></tr>
		+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">Ryr2 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=10090 LK3 transgenic mice])</td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4p9l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4p9l OCA], [http://pdbe.org/4p9l PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4p9l RCSB], [http://www.ebi.ac.uk/pdbsum/4p9l PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4p9l ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4p9l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4p9l OCA], [http://pdbe.org/4p9l PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4p9l RCSB], [http://www.ebi.ac.uk/pdbsum/4p9l PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4p9l ProSAT]</span></td></tr>
	</table>		</table>
	== Function ==		== Function ==
	[[http://www.uniprot.org/uniprot/RYR2_MOUSE RYR2_MOUSE]] Calcium channel that mediates the release of Ca(2+) from the sarcoplasmic reticulum into the cytoplasm and thereby plays a key role in triggering cardiac muscle contraction. Aberrant channel activation can lead to cardiac arrhythmia. In cardiac myocytes, calcium release is triggered by increased Ca(2+) levels due to activation of the L-type calcium channel CACNA1C. The calcium channel activity is modulated by formation of heterotetramers with RYR3. Required for cellular calcium ion homeostasis. Required for embryonic heart development.<ref>PMID:10473538</ref> <ref>PMID:9628868</ref> <ref>PMID:21098440</ref> <ref>PMID:20431056</ref>		[[http://www.uniprot.org/uniprot/RYR2_MOUSE RYR2_MOUSE]] Calcium channel that mediates the release of Ca(2+) from the sarcoplasmic reticulum into the cytoplasm and thereby plays a key role in triggering cardiac muscle contraction. Aberrant channel activation can lead to cardiac arrhythmia. In cardiac myocytes, calcium release is triggered by increased Ca(2+) levels due to activation of the L-type calcium channel CACNA1C. The calcium channel activity is modulated by formation of heterotetramers with RYR3. Required for cellular calcium ion homeostasis. Required for embryonic heart development.<ref>PMID:10473538</ref> <ref>PMID:9628868</ref> <ref>PMID:21098440</ref> <ref>PMID:20431056</ref>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Ryanodine receptors (RyRs) form channels responsible for the release of Ca(2+) from the endoplasmic and sarcoplasmic reticulum. The SPRY2 domain in the skeletal muscle isoform (RyR1) has been proposed as a direct link with L-type calcium channels (CaV1.1), allowing for direct mechanical coupling between plasma membrane depolarization and Ca(2+) release. Here we present the crystal structures of the SPRY2 domain from RyR1 and RyR2 at 1.34-1.84 A resolution. They form two antiparallel beta sheets establishing a core, and four additional modules of which several are required for proper folding. A buried disease mutation, linked to hypertrophic cardiomyopathy and loss-of-function, induces local misfolding and strong destabilization. Isothermal titration calorimetry experiments negate the RyR1 SPRY2 domain as the major link with CaV1.1. Instead, docking into full-length RyR1 cryo-electron microscopy maps suggests that the SPRY2 domain forms a link between the N-terminal gating ring and the clamp region.
		+
		+	Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain.,Lau K, Van Petegem F Nat Commun. 2014 Nov 5;5:5397. doi: 10.1038/ncomms6397. PMID:25370123<ref>PMID:25370123</ref>
		+
		+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
		+	</div>
		+	<div class="pdbe-citations 4p9l" style="background-color:#fffaf0;"></div>

	==See Also==		==See Also==
Line 16:		Line 26:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Lk3 transgenic mice]]
	[[Category: Lau, K]]		[[Category: Lau, K]]
	[[Category: Petegem, F Van]]		[[Category: Petegem, F Van]]

OCA at 19:09, 4 August 2016

OCA — Thu, 04 Aug 2016 19:09:46 GMT

←Older revision		Revision as of 19:09, 4 August 2016
Line 1:		Line 1:
		+
	==Crystal Structure of mouse Ryanodine Receptor 2 SPRY2 Domain (1080-1253) disease mutant A1107M==		==Crystal Structure of mouse Ryanodine Receptor 2 SPRY2 Domain (1080-1253) disease mutant A1107M==
	<StructureSection load='4p9l' size='340' side='right' caption='[[4p9l]], [[Resolution\|resolution]] 1.44Å' scene=''>		<StructureSection load='4p9l' size='340' side='right' caption='[[4p9l]], [[Resolution\|resolution]] 1.44Å' scene=''>
Line 4:		Line 5:
	<table><tr><td colspan='2'>[[4p9l]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4P9L OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4P9L FirstGlance]. <br>		<table><tr><td colspan='2'>[[4p9l]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4P9L OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4P9L FirstGlance]. <br>
	</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4pni\|4pni]]</td></tr>		</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4pni\|4pni]]</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4p9l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4p9l OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4p9l RCSB], [http://www.ebi.ac.uk/pdbsum/4p9l PDBsum]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4p9l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4p9l OCA], [http://pdbe.org/4p9l PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4p9l RCSB], [http://www.ebi.ac.uk/pdbsum/4p9l PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4p9l ProSAT]</span></td></tr>
	</table>		</table>
	== Function ==		== Function ==
	[[http://www.uniprot.org/uniprot/RYR2_MOUSE RYR2_MOUSE]] Calcium channel that mediates the release of Ca(2+) from the sarcoplasmic reticulum into the cytoplasm and thereby plays a key role in triggering cardiac muscle contraction. Aberrant channel activation can lead to cardiac arrhythmia. In cardiac myocytes, calcium release is triggered by increased Ca(2+) levels due to activation of the L-type calcium channel CACNA1C. The calcium channel activity is modulated by formation of heterotetramers with RYR3. Required for cellular calcium ion homeostasis. Required for embryonic heart development.<ref>PMID:10473538</ref> <ref>PMID:9628868</ref> <ref>PMID:21098440</ref> <ref>PMID:20431056</ref>		[[http://www.uniprot.org/uniprot/RYR2_MOUSE RYR2_MOUSE]] Calcium channel that mediates the release of Ca(2+) from the sarcoplasmic reticulum into the cytoplasm and thereby plays a key role in triggering cardiac muscle contraction. Aberrant channel activation can lead to cardiac arrhythmia. In cardiac myocytes, calcium release is triggered by increased Ca(2+) levels due to activation of the L-type calcium channel CACNA1C. The calcium channel activity is modulated by formation of heterotetramers with RYR3. Required for cellular calcium ion homeostasis. Required for embryonic heart development.<ref>PMID:10473538</ref> <ref>PMID:9628868</ref> <ref>PMID:21098440</ref> <ref>PMID:20431056</ref>
		+
		+	==See Also==
		+	*[[Ryanodine receptor\|Ryanodine receptor]]
	== References ==		== References ==
	<references/>		<references/>

OCA at 12:16, 25 December 2014

OCA — Thu, 25 Dec 2014 12:16:18 GMT

←Older revision		Revision as of 12:16, 25 December 2014
Line 6:		Line 6:
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4p9l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4p9l OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4p9l RCSB], [http://www.ebi.ac.uk/pdbsum/4p9l PDBsum]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4p9l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4p9l OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4p9l RCSB], [http://www.ebi.ac.uk/pdbsum/4p9l PDBsum]</span></td></tr>
	</table>		</table>
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/RYR2_MOUSE RYR2_MOUSE]] Calcium channel that mediates the release of Ca(2+) from the sarcoplasmic reticulum into the cytoplasm and thereby plays a key role in triggering cardiac muscle contraction. Aberrant channel activation can lead to cardiac arrhythmia. In cardiac myocytes, calcium release is triggered by increased Ca(2+) levels due to activation of the L-type calcium channel CACNA1C. The calcium channel activity is modulated by formation of heterotetramers with RYR3. Required for cellular calcium ion homeostasis. Required for embryonic heart development.<ref>PMID:10473538</ref> <ref>PMID:9628868</ref> <ref>PMID:21098440</ref> <ref>PMID:20431056</ref>
		+	== References ==
		+	<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: Lau, K.]]	+	[[Category: Lau, K]]
-	[[Category: Petegem, F Van.]]	+	[[Category: Petegem, F Van]]
	[[Category: Calcium]]		[[Category: Calcium]]
	[[Category: Ion channel]]		[[Category: Ion channel]]

OCA at 08:56, 5 November 2014

OCA — Wed, 05 Nov 2014 08:56:28 GMT

←Older revision		Revision as of 08:56, 5 November 2014
Line 1:		Line 1:
-	'''~~Unreleased structure~~'''	+	==Crystal Structure of mouse Ryanodine Receptor 2 SPRY2 Domain (1080-1253) disease mutant A1107M==
-		+	<StructureSection load='4p9l' size='340' side='right' caption='[[4p9l]], [[Resolution\|resolution]] 1.44Å' scene=''>
-	~~The entry~~ 4p9l is ~~ON HOLD until Paper Publication~~	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>[[4p9l]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4P9L OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4P9L FirstGlance]. <br>
-	~~Authors~~: Lau, K.~~, Van~~ Petegem, F.	+	</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4pni\|4pni]]</td></tr>
-		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4p9l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4p9l OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4p9l RCSB], [http://www.ebi.ac.uk/pdbsum/4p9l PDBsum]</span></td></tr>
-	~~Description~~:	+	</table>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Lau, K.]]
		+	[[Category: Petegem, F Van.]]
		+	[[Category: Calcium]]
		+	[[Category: Ion channel]]
		+	[[Category: Metal transport]]
		+	[[Category: Signalling]]
		+	[[Category: Transport protein]]

OCA at 06:26, 30 April 2014

OCA — Wed, 30 Apr 2014 06:26:41 GMT

←Older revision		Revision as of 06:26, 30 April 2014
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 4p9l is ON HOLD	+	The entry 4p9l is ON HOLD until Paper Publication

	Authors: Lau, K., Van Petegem, F.		Authors: Lau, K., Van Petegem, F.

	Description:		Description:

OCA: Protected "4p9l" [edit=sysop:move=sysop]

OCA — Wed, 09 Apr 2014 05:55:09 GMT

Protected "4p9l" [edit=sysop:move=sysop]

←Older revision

Revision as of 05:55, 9 April 2014

OCA: New page: '''Unreleased structure''' The entry 4p9l is ON HOLD Authors: Lau, K., Van Petegem, F. Description:

OCA — Wed, 09 Apr 2014 05:55:08 GMT

New page: '''Unreleased structure''' The entry 4p9l is ON HOLD Authors: Lau, K., Van Petegem, F. Description:

New page

'''Unreleased structure'''

The entry 4p9l is ON HOLD

Authors: Lau, K., Van Petegem, F.

Description: